by
Professor Kauko K. Mäkinen
Institute of Dentistry, University of Turku, Finland
Introduction
Xylitol
is a five-carbon sugar alcohol, a natural carbohydrate
which occurs freely in certain plant parts (for
example, in fruits, and also in products made
of them) and in the metabolism of humans (1).
Xylitol has been known to organic chemistry at
least from the 1890's. German and French researchers
were obviously the first ones who made xylitol
chemically more than 100 years ago. This reaction
was accomplished by means of sodium amalgam reduction
of D-xylose (wood sugar). Owing to the obvious
impurity of the then raw material, the first xylitol
preparation was a syrupy mixture also containg
small amounts of sugar alcohols other than xylitol.
The definitive characterization and purification
of xylitol to polarographic purity was accomplished
already in the 1930's. The first successful crystallization
of xylitol, after reduction of purified D-xylose,
took place during the second world war. This product
was not, however, a stable form of xylitol. A
stable, crystalline form was obtained slightly
thereafter.
Although
xylitol has a relatively long organic chemical
history, the first half of this century was rather
eventless from xylitol's point of view; xylitol
was regarded as one of the numerous sweet carbohydrates
organic chemists isolated at those times. Scientists
obviously did not realize the biologic properties
of xylitol until researchers started to exploit
its insulin-independent nature after the World
War II. Frontrunners in these developments were
Japan, Germany and the [former] Soviet Union.
In Japan, xylitol was used, for instance, in the
resuscitation of patients from diabetic coma.
Xylitol
thus remained mostly as a research chemical until
the war-associated sugar shortage in some countries,
such as Finland, forced engineers and chemists
to search for alternative sweeteners. Such substances
were supposed to be present, for example, in hardwood.
Researchers and engineers at the former Finnish
Sugar Co. Ltd. succeeded to develop an industrial
procedure for small-scale xylitol production,
but the matter was temporarily put aside in the
advent of peace; the sugar shortage subsided.
The idea was not totally forgotten, however, and
the process was being gradually improved. In 1975
the Finnish company began the first truly large-scale
production of xylitol in Kotka, a small town located
in South Finland. Simultaneously, a Swiss company
(F. Hoffman La-Roche) had shown interest in xylitol.
The two companies founded a joint venture (Xyrofin)
in 1976. Later, Xyrofin became a wholly-owned
subsidiary of the Finnish Sugar Co. (currently
Cultor). At the same time, other companies located
in the [former] Soviet Union, China, Japan, Germany,
Italy, etc. had produced xylitol mostly for domestic
markets. Before 1970, xylitol was mainly used
in these countries as a sweetener in the diabetic
diet or in parenteral nutrition (infusion therapy).
Use of xylitol for dental purposes commenced in
the 1970's: the first xylitol chewing gum was
launced in Finland in 1975 and in the USA in the
same year but a few months later.
Various
forest and agricultural materials rich in hemicellulose
have been used as a raw material in xylitol manufacturing.
Hemicellulose is chemically a xylan, a long polysaccharide
molecule consisting of D-xylose units. Xylans
(which in turn are examples of so-called pentosans)
are typically present in certain hardwoods (such
as birch and beech), rice, oat, wheat and cotton
seed hulls, various nut shells, straw, corn cobs
and stalks, sugar cane bagasse, etc. According
to this terminology, pentosans are polysaccharides
consisting of five-carbon pentose sugars, such
as D-xylose. (Glucans consist of six-carbon D-glucose
units, and represent spesific hexosans, important
in the growth of dental plaque.) In the manufacturing
process of xylitol (2), the xylan molecules are
first hydrolyzed into D-xylose. The latter is
chemically reduced to xylitol which can be separated
by large-scale column chromatography. Xylitol
is finally crystallized. The entire process is
complicated and demands great engineering skills
and experience. The amounts of xylitol present
freely in plants are too low for industrial exploitation.
Xylitol can, of course, be synthesized by means
of organic chemical procedures, but the usage
of D-xylose as a starting material is currently
more feasible. Xylitol can also be made by means
of bacterial fermentations which utilize D-xylose,
D-glucose, or other suitable raw materials as
substrates. These processes have not been economically
feasible.
The
chemical profile of xylitol; terminology
Xylitol
is a natural sugar alcohol of the pentitol type,
i.e. the xylitol molecule contains five carbon
atoms and five hydroxyl groups (Fig. 1). Therefore,
xylitol can be called a pentitol. Xylitol belongs
to the polyalcohols (polyols) which are not, strictly
speaking, "sugars" which traditionally
include certain nutritive carbohydrate sweeteners
(sucrose, corn sugar, corn syrup, invert sugar,
D-fructose, D-glucose, etc.; in some reports the
term "sugars" is collectively used to
refer to mono- and disaccharides). However, the
legitimacy for including polyols in the sugar
field results from biochemical relationships;
polyols are formed from, and can be converted
to, sugars (i.e. aldoses and ketoses). Some chemical
encyclopedias define sugars as crystalline, sweet
carbohydrates. The sugar alcohols thus fall in
this category.
To
fully understand the dental effects of xylitol,
it is important to refer to the structural differences
between various dietary polyols (3). Sorbitol
is another sugar alcohol, a hexitol type of polyol,
owing to its 6-carbon structure. Because of this,
sorbitol can support the growth of cariogenic
mutans streptococci and other oral bacteria which
are not normally able to utilize xylitol for growth.
Because of evolutionary expediency, cariogenic
organisms prefer 6-carbon ("hexose-based")
structures, such as D-glocose, as an energy source.
Therefore, it is important to akcnowledge the
inevitable biochemical differences between xylitol
(a pentitol and pentose-derived) and sorbitol
(a hexitol and hexose-derived), and to understand
the nomenclature-related definitions described
above.
In
spite of the existence of some differences between
the various sugar alcohols, xylitol and most other
polyols also display dentally interesting common
properties: they can form certain type of complexes
with calcium and certain other polyvalent cations.
Such Ca-xylitol complexes can be present, for
example, in the oral cavity and in the intestines.
In the former, such complexes may contribute to
the remineralization of demineralized enamel and
dentine caries lesions observed in subjects who
habitually consume xylitol. In the intestines,
those complexes can facilitate the absorption
of calcium through the gut wall; this effect has
been suggested to play a role in the xylitol-associated
prevention of osteoporosis in experimental animals
(4). From the dental point of view, the role of
xylitol (and certain other polyols) as stabilizers
of the salivary calcium and phosphate ions may
be important. It is possible that xylitol stabilizes
the calcium phosphate system present in saliva
in the same manner some salivary peptides (such
as statherin) do (5).
Xylitol
is about twice as sweet as sorbitol. When eaten
in solid or crystalline form (such as in chewing
gum), xylitol gives a pleasant cool and fresh
sensation owing to its high endothermic heat of
solution. The caloric content of xylitol is approximately
the same as that of "sugar"; in practice,
however, xylitol, when eaten as part of a mixed
diet, may provide somewhat less calories than
sugar.
Metabolic
features of xylitol
For
the understanding of the oral safety of xylitol,
one has to briefly describe the human metabolism
of this carbohydrate. Xylitol is a natural intermediate
product which regularly occurs in the glucose
metabolism of man and other animals, and also
in the metabolism of several plants and microorganisms.
As a result of the ease with which it is converted
in the metabolism, xylitol has a low steady-state
concentration in human blood. In man, the normal
blood xylitol level ranges between 0.03 and 0.06
mg per 100 ml. The excretion of xylitol in the
urine is approximately 0.3 mg per hour; there
is normally no significant difference in this
sense between healthy and diabetic subjects.
In
man, ingested xylitol and sorbitol are absorbed
through the gut wall at virtually the same rate,
and appreciably more slowly than D-glucose and
D-fructose. Both polyols are absorbed passively.
In most healthy subjects, an adaptive increase
in the activity levels of an enzyme (a non-specific
polyol dehydrogenase) greatly increases the rate
of xylitol absorption in a few days. This is not
the case with sorbitol. In unadapted subjects
xylitol doses of about 0.5 g per kg body weight
may result in transient soft stools (osmotic diarrhea).
Xylitol is slowly absorbed from the digestive
tract owing to the absence in the intestinal mucosa
of a specific transport system for xylitol. Consequently,
about one third of the ingested xylitol (when
large single doses are taken in) is absorbed,
subsequently entering the hepatic metabolic system.
The other two thirds of the ingested xylitol will
reach the distal parts of the intestinal tract
where xylitol will be broken down by gut bacteria.
The end products are mainly short-chain fatty
acids, most of which will normally be absorbed
and utilized by the body. When very small quantities
of xylitol are consumed (as in one piece of chewing
gum), it is possible that proportionally larger
amounts are directly absorbed.
After
appropriate adaptation, xylitol has been administered
to human subjects in amounts of 200 g and higher
per day without diarrhea occurring. In practice,
usually not more than 50-70 g daily, spread evenly
throughout the day, should be given. Dentally
effective quantities may vary between about 1
and 20 g per day, preferably between 6 to 12 g.
Owing to the slow absorption of xylitol, it has
sometimes been characterized as "glucose
with delay", a property that can be advantageous
in certain clinical situations. Premature infants
possess full capacity to metabolize xylitol.
Xylitol
supplies large amounts of liver glycogen, or primarily
D-glucose. Xylitol is oxidized to carbon dioxide
and water by the normal, physiologic pathway of
carbohydrate breakdown. About 85% of the xylitol
turnover in the body takes place in the liver.
About 10 % is metabolized extrahepatically in
the kidneys, and the small remainder is used up
by blood cells, the adrenal cortex, lung, testes,
brain, fat tissue, etc. These figures are similar
regardless of the way of administration, i.e.
whether oral or by the intravenous route. There
is a small difference between endogenous ("natural")
xylitol and that which is supplied from outside,
for example, when a xylitol-containing diet is
consumed. Endogenous xylitol is the physiologic
intermediate product from D-xylulose and L-xylulose
(these are the keto-sugars corresponding to xylitol).
This reaction takes place in the mitochondria
catalyzed by enzymes which are specific for xylitol.
By contrast, exogenous (ingested) xylitol is slowly
absorbed, and eventually enters the portal circulation
and the liver where it is dehydrogenated in the
cytoplasm of the liver cells by the above mentioned
non-specific polyol dehydrogenase enzyme which
can also act on sorbitol. This enzyme is a key
enzyme in xylitol metabolism and largely determines
the metabolic rate of xylitol. When xylitol is
given for a few days, an adaptation takes place:
the enzyme's levels are increased so that the
metabolic capacity of a subject who is accustomed
to xylitol, is appreciably augmented.
Because
xylitol occurs naturally in agricultural and forest
products, xylitol also occurs in various foods
used by man. The dietary sources containing relatively
high quantities of xylitol are plums, raspberries
and cauliflower (0.3 to 0.9 g per 100 g dry matter;
the quantities vary depending on the season and
they also vary between plant varieties). The presence
of free xylitol in food indicates that man and
certain domestic animals have consumed xylitol
during their entire evolution. In humans, relatively
large amounts of xylitol (viz. 5 to 15 g/day)
are formed as a metabolic intermediate product
of carbohydrate metabolism.
In
conclusion, xylitol, D-fructose and sorbitol are
converted into D-glucose and various metabolites
of D-glucose in the intermediate metabolism, and
thus brought into the main stream of carbohydrate
metabolism, and either stored as glycogen, oxidized
to carbon dioxide and water, or used as building
material for the biosynthesis of substances such
as lipids. Because of the slow absorption rate,
the metabolic capacity is never exceeded when
xylitol is administered by mouth.
The
usage of xylitol as a sugar substitute has the
following physiologic advantages:
(a)
Xylitol has a pleasant taste and a sweetness which
equals that of sucrose.
(b)
With correct xylitol dosage, carbohydrate tolerance
is increased.
(c)
Small xylitol doses stabilize the metabolic situation
in unstable diabetics.
(d)
Xylitol has antiketogenic properties.
(e)
Xylitol is non- and anticariogenic.
Oral and metabolic safety of xylitol
Studies in humans and rodents
have shown that xylitol, when appropriately administered
orally with adaptation, is well tolerated and
safe to levels of at least 90 g/day, with no subjective
or objective adverse findings. Somewhat less insulin
is released into the blood during xylitol administration
than during glucose administration.
The oral and metabolic safety
of xylitol has been assessed by various international
and national regulatory authorities. For example,
in 1983 the Joint Expert Committee on Food Additives
(JEFCA) of two United Nations agencies (FAO and
WHO) allocated an "Aceptable Daily Intake"
(ADI) definition "not specified" for
xylitol. This indicates that no special consumption
limits were needed for xylitol. In detail, JECFA
recommended:
(a) An unlimited ADI based on
the safety of xylitol. This type of specification
reflects the safest category this Committee can
place a food additive. The specification is comparable
to that of sorbitol.
(b) No additional toxicological
studies were recommended.
Of the numerous positive public
health evaluations of xylitol one should mention
the FASEB report of the year 1986. FASEB (Federation
of American Societies for Experimental Biology)
reports are based on comprehensive literature
reviews and the scientific opinions of knowledgeable
investigators engaged in work in relevant areas
of biology and medicine. In 1986 FASEB's expert
panel completed a report on the health aspects
of sugar alcohols and lactose. Based on the comprehensive
body of scientific information, the FASEB report
concluded that:
(a) No significant safety concerns
would be expected from use of xylitol in humans,
and that
(b) Xylitol appears to have the
same safety profile as other sugar alcohols, such
as sorbitol and D-mannitol.
As a further proof of xylitol's
metabolic safety, one should mention the traditional
use of xylitol as a source of energy in infusion
therapy (parenteral nutrition; Table I). Especially
German and Japanese physicians have with great
success used xylitol, in combination with other
carbohydrates and amino acids, for this purpose.
This practice is based, among other things, on
the non-involvement of insulin in the initial
utilization by the human cells of xylitol, and
on the ability of xylitol to exploit several metabolic
"entrancies" into the liver, compared,
for instance, with sorbitol which biochemically
speaking has only one "entry point"`into
the metabolism.
Xylitol has long been used as
a sweetener in the diabetic diet; diabetic patients
have been found to consume up to 70 g xylitol
per day without any adverse reactions. As discussed
below, these xylitol levels by far exceed those
recommended for dental purposes. The public health
evaluation of xylitol has been in greater detail
reviewed elsewhere (6 ).
As already stated above, it is
necessary to make a clear difference between the
oral (enteral) and parenteral administration of
xylitol. Although metabolic studies indicate that
the capacity of the human body to turn over xylitol
is substantial, the oral consumption of xylitol
will never lead to blood xylitol levels that would
be too high. This results from the slow absorption
rate of xylitol through the gut wall. This indicates
that too high oral doses may cause transient osmotic
diarrhea. The laxative effect of large single
doses of xylitol is indeed the only adverse effect
reported in studies dealing with oral administration
of xylitol. Similar effects can be caused by other
polyols, and also by D-fructose and lactose (milk
sugar). Field experience indicates that humans
tolerate xylitol better than sorbitol and D-mannitol.
In conclusion, scientific articles and clinical
studies have shown, that the gastrointestinal
effects of xylitol occur at levels that are much
higher than those needed to achieve the dental
benefits, such as those used by diabetic patients.
Based on the scientific and public
health evaluations, xylitol has been approved
in virtually all industrialized countries to be
used in oral hygiene products and in other products
to promote oral health. Typical dentally benefical
xylitol products are chewing gums, lozenges, dragées
and hard caramels. In reality, the range of xylitol
products for consumer and other uses has been
much broader (Table I). In view of the above developments,
it is important to acknowledge the recent resolution
made in Japan regarding xylitol. The Japanese
Ministry of Health and Welfare finished in 1996
a long-term scientific evaluation of xylitol and
approved, in spring 1997, xylitol officially as
a safe food additive in Japan. This positive public
health-related decision will most likely greately
accelerate the development of oral health-promoting
xylitol products in Japan and its neighbouring
countries.
Some
potential future uses of xylitol
Owing to the molecular properties
of xylitol, it will most likely have new biologic,
dietary and medical applications in the furute.
One promising approach is the possible use of
xylitol as a dietary agent to prevent midear infections
in young children. This effect is based on the
growth inhibition by xylitol of alpha-hemolytic
streptococci, including Streptococcus pneumoniae.
As one consequence of this, the usage of xylitol
chewing gum by young day-care center children
was shown to reduce the occurrence of acute otitis
media and antimicrobial treatment received during
the gum-using period (7). It is possible that
the virulent bacterial flora present in the entire
aero-digestive tract of man, can be favourably
affected by systematic xylitol use. Xylitol, by
virtue of its pentitol nature, modifies the outer
environment of selected pathogenic organisms and
the outer structures of the organisms themselves.
Such changes may result in a lowered ability of
the organisms to adhere onto epithelial cell surfaces
and other host tissue surfaces, reducing the risk
of infection. It is clear, however, that the above
otitis media-related observations must be verified
by independent studies before further conclusions
can be made.
Xylitol
compared with other sweeteners
The following treatise will be
restricted to deal with differences between dental
and oral biologic effects of some common dietary
sweeteners. Therefore, the "sugar alcohol
nature" of xylitol must be emphasized. For
a better understanding of the dental effects of
xylitol, one has to recall the chemical features
of the xylitol molecule described above. All dietary
sugar alcohols share several common properties
that make them biologically unique. Some of them
are as follows:
(a) The absence of reducing carbonyl
group. This makes sugar alcohols chemically somewhat
less reactive than corresponding aldoses and ketoses;
some of the sugar alcohols are, therefore, less
capable of supporting plaque growth.
(b) The reducing power. Regardless
of the above relative inertness of polyols in
the human oral cavity, some sugar alcohols may
actively participate in metabolic reactions where
their "extra" hydrogen atoms can be
deposited on other metabolites, to form other
reduced products of metabolism, which are less
harmful to the tooth structure.
(c) Complex formation. As stated
above, sugar alcohols can form complexes with
Ca and certain other metal cations, thereby possibly
affecting the metabolism of those cations in the
oral cavity. Consequently, some sugar alcohols
may contribute to the physiologic remineralization
reaction whereby calcium phosphate salts are deposited
in calcium-deficient sites.
(d) Protein stabilizing effect.
Sugar alcohols can protect proteins in aqueous
solutions against denaturation and other damage.
It is thus possible that, for example xylitol,
protects salivary proteins.
As a result of evolutionary expediency,
human cariogenic bacteria have developed effective
enzyme systems which utilize the chemical energy
present in some ubiquitous dietary carbohydrates.
Those carbohydrates are normally based on six-carbon
skeletons (or multiples thereof) and normally
have an aldose or a ketose structure. Suitable
examples of such sugars are D-glucose, D-fructose
(which are six-carbon monosaccharides) and sucrose
(which is a disacacharide consisting of D-fructose
and D-glucose). Starch consists of long chains
of D-glucose molecules, and can be broken down
in the oral cavity by plaque and salivary enzymes
to yield D-glucose. All simple dietary sugars
(the above three serve only as examples) may produce
acids and may serve as building material in the
formation of adhesive plaque polysacharides (glucans
were above mentioned as an example of such molecules).
Sucrose, D-glucose and D-fructose are normally
in this sense effectively utilized by cariogenic
bacteria. The upshot of this utilization can be
the formation of potently cariogenic plaque. Xylitol
is unable to form such plaque because the xylitol
molecule contains only five carbon atoms. For
the same reason, xylitol does not produce lactic
acid.
No study has shown that the oral
bacteria become adapted to utilize xylitol for
effective acid and polysaccharide production.
Sorbitol, on the other hand, has been shown to
stimulate plaque growth; adaptation to sorbitol
occurs. Sorbitol itself does not give rise to
large amounts of lactic acid in human dental plaque,
but the ability of sorbitol to promote the growth
of cariogenic streptococci makes it indirectly
caries-promoting. (However, sorbitol is by far
safer from the cariologic point of view than sugar.)
It is irrational to compare xylitol
with artificial, intense sweeteners (such as saccharin,
cyclamate, aspartame, etc.), because these substances
are used at totally different chemical concentrations
in food. The synthetic sweeteners´ chemical
activity is, therefore, so low in most foods that
they rarely exert any specific, significant, oral
health-promoting effects. Xylitol, being a natural
dietary carbohydrate, must be used at chemical
levels corresponding to those of regular table
sugar. Such concentrations are more likely to
display specific effects on oral microorganisms
and on oral tissues.
References
1. Mäkinen KK. Biochemical
principles of the use of xylitol in medicine and
nutrition with special consideration of dental
aspects. Birkhäuser Verlag, Basel, 1978.
2. Aminoff C. New carbohydrate
sweeteners. In "Sugars in Nutrition"
(Sipple HL, McNutt KW, eds), Chapter 10, Academic
Press, New York 1974.
3. Mäkinen KK. Latest dental
studies on xylitol and mechanism of action of
xylitol in caries limitation. In "Progress
in Sweeteners" (Grenby TH, ed.), Chapter
13, Elsevier, London 1989.
4. Svanberg M, Knuuttila M. Dietary
xylitol prevents ovariectomy-induced changes of
bone inorganic fraction in rats. Bone Miner (1994)
26:81-88.
5. Mäkinen KK, Söderling
E. Solubility of calcium salts, enamel, and hydroxyapatite
in aqueous solutions of simple carbohydrates.
Calcif Tissue Int (1984) 36:64-71.
6. Mäkinen KK. Dietary prevention
of dental caries by xylitol - clinical effectiveness
and safety. J Appl Nutr (1992) 44:16-28.
7. Uhari M, Kontiokari T, Koskela
M, Niemelä M. Xylitol chewing gum in prevention
of acute otitis media: double blind randomised
trial. Br Med J (1996) 313:1180-1184.
|